Tag Archives: Cancer Studies

Links to Cancer and Processed Foods are Studied by Brazilian and French Researchers

What You Put in Your Body Could Be Affecting Your Likelihood of Catching Cancer.
What You Put in Your Body Could Be Affecting Your Likelihood of Catching Cancer.

Following a nutritional diet during cancer treatment is essential to boosting your immune system and energy level. A recently published study indicates that there may be a link between highly processed foods and development of cancer.

Does Diet Affect Cancer Risk?

A recent issue of medical journal BMJ included the report of a study conducted by a team of French and Brazilian scientists. After reviewing the diets and medical records of 104,980 French adults, the researchers found that an increase in consumption of processed foods paralleled an increase in cancer risk.

Specifically, data showed that eating 10 percent more highly processed foods was accompanied by a 12 percent increase in overall cancer risk and 11 percent increase in breast cancer risk.

Items defined as “highly processed foods” included ready-to-eat meals, carbonated drinks and reconstituted meat found in products like chicken nuggets. According to the research team, these types of foods constitute nearly half of the energy intake in many developed countries.

Making Healthy Choices

No link was found with moderately processed foods such as cheese, canned vegetables and freshly made bread. Not surprisingly, minimally processed foods such as fruits and vegetables, meat, eggs and fish were linked to a lower risk of cancer.

The team said that study limitations prevented firm conclusions. Further research can clarify the implications and help to identify the specific elements in foods that link to cancer.

Issels®: The Leader in Immunotherapy Cancer Treatment

At Issels®, nutritional immunotherapy is one of the components in our individually developed cancer treatment programs. Contact us for more information about our non-toxic, state-of-the-art immunotherapy treatments.

NCI Studies Disparities in Cancer Treatment in Rural Communities

If You and Your Family Does Choose to Live Out in the Country, Make Sure You Live Close to a Location with Good Healthcare Providers.
If You and Your Family Does Choose to Live Out in the Country, Make Sure You Live Close to a Location with Good Healthcare Providers.

Does where you live affect your chances of surviving cancer? Recent studies are putting a focus on the disparities of cancer treatment between rural and urban communities.

Equal Access to Health Care?

Overall, cancer death rates in the United States have declined over the last 40 years. Unfortunately, two studies from the National Cancer Institute and Centers for Disease Control have revealed that cancer death rates are higher in rural areas and declining at a much slower pace.

NCI has a history of promoting cancer control in Appalachia, with efforts directed at prevention and early detection. Issues surrounding last year’s presidential election have further raised the visibility of questions about access to quality health care.

As research methods and tools become more sophisticated, scientists have the advantage of more granular data. This allows for more detailed plotting of disease patterns and trends as they apply to specific geographic regions.

Healthcare Organizations Rise to the Challenge

Growing acknowledgement of the problem is also raising the sense of urgency. Researchers at the University of Washington found that differences in life expectancy by county are large and growing even larger.

NCI, along with federal agencies such as the Centers for Medicare and Medicaid Services, are joining forces to collaborate on research and implementation. The next big step is a May 2018 meeting that NCI is convening among major organizations in the cancer community.

Issels®: Accessible and High-Quality Cancer Treatment

Our integrative immunotherapy programs incorporate multiple elements to create the best possible treatment for your particular diagnosis. Contact us for more information about cancer vaccines, NK cells and other non-toxic treatment methods.

Cancer Cells are Rogues that Dedifferentiate: An Interesting New Study

Learning About Cancer
Learning About Cancer

Issels® Center for Immuno-Oncology recently discovered an interesting study, linking the Darwinian theory of evolution to the origin of cancer. Life, a delicate web of biological compromises, can go awry with the rogue dedifferentiation of a single cell…

A harmonious cooperative
In evolutionist theory, cooperation gives rise to multicellular organisms from plants to mammals. Surrendering autonomy, single cells prosper with the whole rather than the ruthless competition of their predecessors, singular primordial cells.

Different, but the same
Cells in a healthy multicellular organism differentiate, performing specialized tasks and working for the good of the whole: skin, blood, bone cells and more benefit each other.

Getting greedy
What happens when a cell breaks loose, selfishly multiplies and expands its territory? The free-for-all of Darwin’s pond results in cancer, a selfish dedifferentiation that benefits only itself through excess reproduction and overconsumption of resources. Pathological behavior that ultimately degrades the environment to the rogue’s own advantage, but which ultimately destroys the ecosystem, resulting in its own demise.

Deadly deception
How does this result from a single rogue cell? The cancer cell divides and mutates, creating separate lineages (subclones) with different abilities. Each family of mutated cells works together to make what is necessary for the growth of the tumor, even tricking healthy cells to do their own bidding.

Is there a choice?
The study identified similar kinds of “cellular cheating” in most multicellular organisms: mammals, birds, reptiles, fish, insects – even in plants and fungi; an inescapable consequence of multicellularity.

Is your body’s rebellious side getting the better of you? Issels® can help bring your body back to balance. Contact us today.

T-Cells Take Center Stage in This Cancer Treatment Protocol

Cancer Gene
T- Cells Take Over

Being told you have cancer is hard to hear from your doctor. Fighting it is harder. Here at Issels®, we respect how difficult it is for you and we do anything we can to help you in your battle. Sometimes that means researching new treatments that can potentially save your life.

An article in Science Mag talks about one of these new treatments. Researchers have tested new cancer drugs that can help improve your immune system. In clinical trials of these drugs on patients with melanoma or lung cancer that were given a poor prognosis, these drugs were able to improve the prognosis in many of the participants. They were useless in patients with colon cancer with the exception of one man, who, after being treated in 2007, showed no sign of his metastatic tumors for several years.

This new drug is an antibody that blocks a receptor on the immune system’s T-cells called PD-1. When tumor cells activate the PD-1 receptor, they can hide T-cells. If this “checkpoint” is blocked by a PD-1 inhibitor, the T-cells can see the tumor cells and attack them. Researchers hypothesize that melanoma and lung cancer respond so well to PD-1 inhibitors because of their multiple mutations. The mutations may alter genes, causing small stretches of abnormal proteins. The immune system tends to see these as unfamiliar proteins, or antigens. The more of these “neoantigens” there are, the greater an attack from T-cells unleashed from a PD-1 inhibitor.

For more on this new research, go to Science Mag to read the full article.

If you have questions about immunotherapy treatments we use at Issels®, come visit our website today.

Molecular Imaging: New Technology to Fight Cancer

Cancer Research
New Molecular Imaging

Once a cancer diagnosis has been made, doctors and patients typically plan a course of treatment. All too often during this period of strategizing, the patient’s quality of life during treatment isn’t taken into account. Radiation and chemotherapy can effectively treat cancer, but they also come with their own list of side effects, some of which can be temporarily debilitating.

A new approach to stage 4 cancer treatment involves molecular imaging. This technology allows doctors to precisely target the most aggressive cancer cells by using a powerful scan that combines a traditional CT with 3-D positron emission tomography (PET). Being able to identify the most dangerous cancer cells allows doctors to perform accurate biopsies and significantly reduce the amount of radiation and chemotherapy treatments needed.

This cutting edge scan can also tell doctors a lot more about how your tumor is behaving. Often times, progress is measured by whether the tumor is shrinking or changing shape. However, this may only be a small part of the picture. Even if your tumor looks the same, the cells may have become less active. Molecular imaging may be able to provide some good news that traditional scans don’t detect.

For those struggling through cancer treatments, a PET scan and molecular imaging may be the solution to enjoying a better quality of life as you fight cancer. Limiting the radiation and chemotherapy treatments will allow you to feel healthier, less stressed and more capable of tackling cancer. If you would like to learn more about the latest in cancer treatments, proven immune boosting techniques and the importance of a positive attitude, be sure to visit the Issels® website today.

Vitamin D Plays a Role in Pancreatic Cancer Unlocking New Potential Treatments

Vitamin D To Reduce Risks of Cancer
Vitamin D is Essential

At our Issels® clinics, our focus is providing treatment programs that work with the patient’s immune system and defense mechanism to naturally eliminate cancer cells.

New treatments on the forefront in the fight against cancer are always good news and when a vitamin is found to be playing a significant role in the treatment of difficult tumors, that makes the news even better.

Pancreatic cancer is a devastating disease with a very low estimated survival rate of five years. A big part of the problem in treating the tumor has been the lack of a complete understanding of a pancreatic tumor’s resistance to current standard treatment.

It is understood that the tumor has the ability to send signals to surrounding cells, called tumor microenvironment. When the cells receive a signal from the tumor, a “shield” surrounds the pancreatic tumor protecting it from drugs and healthy immune cells. With the barrier in place, the tumor can continue to grow.

A study by the Salk Institute has found that a derivative from vitamin D weakens and collapses the shield protecting the tumor. The findings from the study have resulted in both human and animal clinical trials.

The outlook for vitamin D as a positive influence on weakening protective cells surrounding tumors may also mean other difficult tumors, such as those found in the liver, kidney, and lungs, will also be susceptible to treatment.

At Issels®, we are dedicated to providing quality programs and treatments for our patients. If you would like more information about our clinics and our locations in the U.S. and abroad, please contact us by phone or use our convenient online form.